ArticlePathology oncology research : POR2017

Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas.

Elham Kalantari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.